Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a starch powder trick the gut into curbing teen appetite?

NCT ID NCT07823452

Symptom relief Sponsor: Indiana University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Researchers at Indiana University are testing whether a food carbohydrate powder made from raw corn and potato starch can raise levels of GLP-1, a gut hormone that helps people feel full. The trial enrolls 62 adolescents aged 12 to 18 with obesity. For two months, participants drink the powder mixed with water twice daily or a placebo, and researchers measure GLP-1 levels, calorie intake, eating habits, and changes in weight and BMI.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a food carbohydrate supplement made from raw corn starch and raw potato starch that aims to trigger the gut hormone GLP-1
What this could lead to
If it works, a simple starch powder could offer adolescents a food-based way to feel full and eat less, without injections or drugs.
What could go wrong
This is a small Phase 2 trial in 62 teens, so any effect on appetite or weight may be modest and may not hold up in larger studies. Starch powders can cause bloating or gas, and appetite changes do not always translate into lasting weight loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 62 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children ages 12 to ≤18 years and older with obesity, a BMI ≥95% for age and sex * English-speaking subjects * Children who have been on stable dosing of medications for 3 months which secondarily lead to weight gain, weight loss, or appetite suppression * Children able to stay on a stable dose of all concomitant medications throughout the study treatment period Exclusion Criteria: * Females who are or planning to become pregnant or are breastfeeding * Children with malabsorptive disorders including inflammatory bowel disease, Celiac disease, and short bowel syndrome * Children with any intestinal resection * Children with Type 1 or Type 2 Diabetes Mellitus * Children taking any medications or supplements for weight loss within 30 days prior to enrollment in the study * Subject has any condition that, in the opinion of the investigator, would compromise the well-being of the subject or would compromise the study or prevent the subject from meeting or performing study requirements.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity & overweight are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity & overweight

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Riley Hospital for Children at IU Health

    Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.